Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eurartesim in Imported Uncomplicated P. vivax Malaria
NCT02110784Phase 2Terminated
- Sponsor
- Alfasigma
- Start
- Jun 2014
- Primary completion
- Nov 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of dihydroartemisinin in Plasmodium vivax malaria, sponsored by Alfasigma. Started Jun 2014; status: terminated.
02
Drugs
dihydroartemisinin
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT02110784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02110784.